Through the bioinformatics analysis of our dataset and the incorporation of other publicly available prostate cancer datasets4,21–23, we identify ELAVL3, a member of the Embryonic Lethal Abnormal Vision-like RNA-binding protein family, as a key regulator implicated in the initiation and maintenance of neuroendocrine differentiation. This evidence concerns the gene ELAVL3 and prostate carcinoma.